Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment

  • sCD40L-caspase 3 chimeric protein for treating B-cell malignancies
  • Rotem Kedar, Ofra Sabag, Michal Licthenstein, Haya Lorberboum-Galski
  • Cancer, June 2012, Wiley
  • DOI: 10.1002/cncr.27654

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/cncr.27654

In partnership with:

Link to Wiley showcase